<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite NK cells being originally identified because of their ability to kill <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in vitro, only limited information is available on NK cells infiltration of <z:mp ids='MP_0002018'>malignant tumors</z:mp>, especially in humans </plain></SENT>
<SENT sid="1" pm="."><plain>NK cells infiltrating human colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) were analyzed to identify their potential protective role in an antitumor immune response </plain></SENT>
<SENT sid="2" pm="."><plain>The expression and function of relevant molecules were analyzed from different sources, comparing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated NK cells (TANKs) with autologous peripheral blood NK cells (PB-NKs) from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients-the latter in comparison with PB-NKs from <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="3" pm="."><plain>TANKs displayed a profound alteration of their phenotype with a drastic reduction of NK cell receptor expression </plain></SENT>
<SENT sid="4" pm="."><plain>Co-culture experiments showed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells produce modulation in NK phenotype and functionality </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, PB-NKs from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients also exhibited an altered phenotype and profound defects in the ability to activate degranulation and IFN-Î³ production </plain></SENT>
<SENT sid="6" pm="."><plain>For the first time, TANK and PB-NK cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients have been characterized </plain></SENT>
<SENT sid="7" pm="."><plain>It is shown that they are not capable of producing relevant cytokines and degranulate </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, our results suggest that NK cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients present alterations of phenotype and function therefore supporting the progression of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>